Nine hepatic adenomas (HA) diagnosed by contrast-enhanced ultrasound (CEUS) among 123 liver lesions (89 patients) were evaluated retrospectively; five were confirmed through pathological diagnosis. Time-intensity curves (TIC), contrast medium arriving time (AT), peak time (PT) and retrogression time (RT) for HA were compared with 30 hepatocellular carcinomas (HCC) and six focal nodular hyperplasias (FNH). Significant differences existed between HA and poorlydifferentiated HCC in AT, PT and RT, and
Introduction
Hepatic adenoma (HA) is a rare benign tumour that develops in hepatic segments without cirrhosis. 1 -3 It commonly occurs in females with a history of oral contraceptive use and in males who have undergone androgen steroid therapy. 1, 2 Unlike focal nodular hyperplasia (FNH), HA is a true hepatic tumour that is rich in normal and abnormal liver cells but lacking in Kupffer cells and bile ducts, as demonstrated by histological analyses. 4 Typical HA is relatively easy to diagnose; however, atypical cases (with haemorrhage and possible malignant transformation) are difficult to distinguish accurately from hepatocellular carcinomas (HCC), FNH or hypervascular metastatic tumours. Since HA has a heightened risk of haemorrhage or malignant transformation, 3,5 a non-invasive diagnostic approach would be beneficial.
No specific characteristics of HA can be identified on computed tomography, magnetic resonance imaging (MRI) or ultrasound compared with characteristics shown on pathological examination. 3,6 -10 Research indicates that MRI with super paramagnetic iron oxide 11 is helpful for the *XL Zhu, P Chen and H Guo contributed equally to this study.
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Contrast-enhanced ultrasound for hepatic adenoma diagnosis presurgical diagnosis of HA, but signal intensity is unspecific because of the different degrees of necrosis, calcification or fibrosis found in individual cases. 6 -9 As a result, there is no standard guideline for imagebased HA diagnosis. 9 Nevertheless, contrastenhanced ultrasound (CEUS) can be used to visualize specific intravascular features and may provide a new detection method that presents clear images of HA. The present study investigated the value of CEUS in the diagnosis of HA and in the differential diagnosis of HA compared with other liver lesions, namely HCC and FNH.
Patients and methods

PATIENTS
This retrospective study included adult patients who had liver lesions and were treated at the Cancer Research Institute and Hospital of Tianjin Medical University, Tianjin, China, between January 2000 and June 2009. All patients had undergone diagnostic imaging procedures with CEUS. Some also underwent needle biopsy and the remainder had surgical resections. A subset of patients with HCC or FNH -initially identified using CEUS and confirmed by pathological examination -were also randomly selected to serve as controls.
Written informed consent was obtained from all patients enrolled and the study was approved by the Ethics Review Committee of the Cancer Research Institute and Hospital of Tianjin Medical University. All data and information derived from, and pertaining to, the study were under the exclusive control of the investigating radiologists.
IMAGING TECHNIQUES
All subjects were examined with an Aplio colour ultrasound diagnostic apparatus (Toshiba, Tokyo, Japan). A PVT-375BT probe (Toshiba) at a central frequency of 3.5 MHz was used. The second-generation ultrasound contrast agent SonoVue ® (Bracco, Milan, Italy), which has received State Food and Drug Administration approval in China, was used in the study; this contrast agent contains sulphur hexafluoride microbubbles stabilized using phospholipid microcapsules. The mean diameter of the microbubbles is about 2.5 µm and the pH is 4.5 -7.5. SonoVue ® was supplied as a freeze-dried powder in a type 1 glass vial and was dissolved and shaken vigorously with 5 ml of saline prior to use. Then, 2.4 ml of contrast medium was extracted from the vial and immediately administered into the forearm shallow vein of each patient together with 10 ml physiological saline.
IMAGING ANALYSES
The CEUS examinations were performed as follows. First, the numbers of lesions and their location, shape, size, borders, internal echo and blood supply (achieved by asking the patient to hold his or her breath during measurement of the blood-flow spectrum of the lesion) were displayed in twodimensional (2-D) baseline sonography. Secondly, during the dynamic enhancement process, a mechanical index of < 0.1 was selected to avoid microbubble disruption. The timer was set to allow uninterrupted, real-time observation of lesions and peripheral tissue during the dynamicirrigation process. Lesions were observed for ≥ 10 min. After completing the radiography, the content was replayed, the piece was read, image splicing was undertaken and VideoStudio ® Pro X3 multilingual software, version 13.0 (Corel Inc., Fremont, CA, USA) was used to edit continual fragments into an audio-video interleaved (AVI) format. Data recorded in AVI were analysed with Qontrast™ software, version 4.0 (Esaote Inc., Genova, Italy). The time-intensity curve XL Zhu, P Chen, H Guo et al. Contrast-enhanced ultrasound for hepatic adenoma diagnosis (TIC) , contrast medium arriving time (AT), peak time (PT) and retrogression time (RT) were obtained automatically. Morphological characteristics of each lesion were also recorded.
STATISTICAL ANALYSES
Statistical analyses were carried out using the SPSS ® statistical package, version 17.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . The two independent samples t-test was used to analyse the TIC data (including AT, PT, RT) of HA and the control group after contrast. The Cochran-Cox method was used to analyse the significant difference between pairs with heterogeneity. A P-value < 0.05 was considered to be statistically significant.
Results
In total, 89 patients (59 men, 30 women; mean age 55 years, range 21 -78 years), with a total of 123 liver lesions, were included in the study. All patients had undergone diagnostic imaging; 57 underwent needle biopsies and the remaining 32 had surgical resections.
In nine of the 89 patients (three men, six women; mean age 38 years, range 21 -45 years) HA was diagnosed using CEUS. Surgical and pathological findings in these nine cases revealed that five were actual HA cases; however, four were false-positivestwo were well-differentiated HCC and two were FNH. The positive-predictive value for diagnosis of HA was calculated as 55.6%. The five confirmed cases of HA served as the experimental samples. Typically, contrast enhancement of HA had a 'fast-in and slowout' characteristic ( Fig. 1) as it resulted in a centripetal or mixed-filling pattern in the arterial phase with a mean ± SD AT of only 6.56 ± 2.63 s ( Table 1) .
Three subgroups were randomly selected from the remaining patients to serve as controls: 30 patients with HCC (23 men and seven women; mean age 31 years, range 21 -78 years), including 11 well-differentiated and 19 poorly differentiated tumours; and six patients with FNH (three men and three women; mean age 40 years, range 26 -50 years). Controls were initially diagnosed using CEUS and confirmed by pathological examinations. The majority of patients with well-differentiated HCC had background cirrhosis. CEUS in poorly differentiated HCC had a 'fast-in and fast-out' characteristic The differences observed between HA and HCC or FNH in AT, PT and RT are shown in Table 1 . Statistically significant differences were observed between HA and poorly differentiated HCC in terms of AT (P < 0.01), PT (P < 0.02) and RT (P < 0.01). Contrast in poorly-differentiated HCC manifested in a later AT and a faster RT compared with HA. A statistically significant difference between HA and well-differentiated HCC was only found in AT (P < 0.01). No statistically significant differences between HA and FNH were identified. Consequently, the differential diagnosis of HA and FNH was only achievable through reviewing their patterns of enhancement on CEUS: FNH showed a centrifugal filling pattern ( Fig. 3) , whereas HA demonstrated a centripetal filling pattern. There was no statistically significant differences between HA and FNH (P > 0.05).
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The two patients with false-positive HA who were subsequently found to have HCC were reviewed. Neither patient had a history of hepatic cirrhosis. CEUS examinations in both cases had an AT of < 10 s, which was well below the mean of 14.90 s for welldifferentiated HCC (Table 1 ). Because these examinations exhibited a 'fast-in, slow-out' pattern, it was initially presumed that both were cases of HA. Minor differences were, however, observed retrospectively. For example, one of the lesions had an unusually small arterial blood supply (Fig.  4 ). In addition, the TIC indicated that the contrast medium took a shorter time from AT to PT than would be expected in a confirmed case of HA, and was very similar to what would occur in HCC.
When the two false-positive cases of HA who were subsequently found to have FNH were retrospectively reviewed, differences in perfusion appearance and arterial morphology were apparent. One of the falsepositive HA cases had a very slight oval hypoechoic centre, initially described as a small atypical HA of < 2.0 cm with a central necrosis ( Fig. 5 ). FNH is typically characterized by a central stellate scar, 8 and 
the scar can be found in nearly 95% of lesions > 3 cm; although it is only found in 20 -30% of smaller lesions. 4 In both these false-positive HA subsequently found to have FNH, withdrawal of contrast was not observed in the early portal venous phase. This was in contrast to results reported by Dietrich et al., 12 who reported that the central scar in FNH appeared hypoechoic in the portal venous phase.
Discussion
Particularly in males and in patients with large tumours, HA is considered to represent a stimulated proliferation of hepatic cells that carries the risk of undergoing malignant transition. 3, 13 The HA lesions are usually solitary, although multiple lesions have been reported. 3 Histologically, HA consists of a cord-like arrangement of normal hepatocytes, structured in large plates that are separated by dilated sinusoids. 8 The hypervascular nature of HA is due mainly to extensive sinusoids and feeding arteries and to poor connective tissue, 8 all of which contribute to the centripetal blood flow of the lesion such as was visualized with CEUS in the present study. In addition to being slightly larger than normal cells, hepatocytes in HA may have intracellular fat or increased glycogen. 8 Furthermore, HA lacks a portal venous supply and has blind-ending vessels unconnected to the larger veins. Thus, these lesions are perfused solely by arterial pressure derived from peripheral arterial feeding vessels, which may explain why HA is predisposed to haemorrhage. 14 Most cases of HA are hyperechoic in 2-D ultrasound. On dynamic phase images following SonoVue ® injection a typical HA manifests with hypervascular enhancement, with a 'fast in' characteristic in the arterial phase. The flash-filling characteristic of HA correlates with the unique histopathological features of these lesions, i.e. their limited portal venous supply, with few terminal hepatic vein drainages. During the portal venous phase HA then becomes slightly hyperechoic (see Fig. 1 ) and continues slightly hyperechoic or isoechoic compared with normal liver parenchyma during the delayed phase.
The present study revealed statistically significant differences between HA and poorly differentiated HCC in terms of AT, PT and RT. There is a close relationship between AT and blood supply to the lesion: hypervascular lesions are often characterized 4 In general, poorly differentiated cases of HCC have two sources of blood supply, or an arterial-venous shunt, which results in the 'fast-in, fast-out' features observed on CEUS examination. 15, 16 This enhancement pattern was clearly seen in the present study (see Fig. 2) , where a welldefined hyperechoic lesion was observed on the baseline image; a 'fast in' feature was characterized during the arterial phase and an early retrogression in the portal venous phase was visualized on dynamic enhancement.
It is notable that the differences between HA and poorly differentiated HCC that were apparent on histopathological examination in the present study concurred with the statistically significant findings relating to TIC parameters during CEUS examination.
Four false-positive cases were identified using CEUS in the present study: on pathological evaluation two were eventually confirmed as well-differentiated HCC and two were FNH. Patients with welldifferentiated HCC often have background cirrhosis. 17 About 80% of HCC cases appear in cirrhotic populations, and a liver mass in a cirrhotic patient should be first considered as HCC until proven otherwise. 18 On CEUS, cirrhosis has an atypical enhanced pattern consisting of 'fast-in, slow-out', rapid filling in the arterial phase and retained hyperenhancement until the delayed phase, 17 in accordance with haemodynamic changes of arterialization of the liver, intrahepatic shunts, pulmonary arteriovenous shunts and a hyperdynamic circulatory state in hepatic cirrhosis. 19 This may, however, lead to diagnostic confusion with HA. A statistically significant difference in AT between HA and well-differentiated HCC was observed in the present study, which may help to facilitate the accurate diagnosis of both conditions. Neither of the patients with well-differentiated HCC, originally misdiagnosed as HA, had a history of hepatic cirrhosis. In addition, the lesions in both patients had AT of < 10 s. The observations of a 'fast-in, slow-out' enhanced mode, similar to that of HA, resulted in the initial misdiagnoses. One lesion had an abnormally small arterial blood supply and the TIC for both lesions showed that contrast medium took a shorter time to reach PT than would normally be expected for HA (which is longer due to the relatively slower blood flow). In addition, the slope of the ascending branch was sharper: again this is associated with welldifferentiated HCC rather than HA. Together, these differences are more typical of welldifferentiated HCC than HA. As both types of lesion are mainly nourished by hepatic arteries, the contrast medium showed it as a 'fast-in' type.
We believe that differences in endovascular structure and histopathology between HCC and HA can be observed microscopically and that differences may occur at the molecular level. Both lesion types are difficult to distinguish if imaging alone is used, although imaging in combination with TIC analysis is useful. The findings of the present study need to be verified through further research.
The two false-positive cases of HA that were subsequently confirmed as FNH probably resulted from the absence of any notable differences between HA and FNH among the TIC parameters (AT, PT and RT) on CEUS. Although both conditions are benign, it is important that they are diagnosed accurately and distinguished from each other because the therapeutic strategies are different: 5, 20 FNH can be managed conservatively, whereas HA is usually treated with surgery (following the withdrawal of • Received for publication 13 January 2011 • Accepted subject to revision 27 January 2011
• Revised accepted 24 March 2011 Copyright © 2011 Field House Publishing LLP oral contraceptives). 21 By reviewing the relevant literature and undertaking retrospective comparisons, we believe that a tentative differential diagnosis of FNH and HA remains possible based on the different perfusion appearance and morphological characteristics that are observed in these lesions during the dynamic phases of CEUS. 12,13,22 -24 Centrifugal filling is more common in FNH, whereas a centripetal or mixed-filling pattern is more common in HA. 13 Histologically, FNH is characterized by a central stellate scar, normal hepatocytes and a malformed biliary system in which the primary bile ducts are blind and do not extend to the bigger ducts. 9 As a consequence, biliary excretion in FNH is slower than the excretion occurring in normal hepatocytes. As shown in the present study (see Fig. 3 ), typical FNH has an asymmetrical echo in 2-D ultrasound and a homogeneous hyperechoic enhancement during the arterial phase, without washout following the portal venous and delayed phases. A typical stellate scar produces a hypoechoic area on CEUS, whereas delayed hyperintensity is apparent on contrastenhanced MRI. 25 One possible reason for this is the strict intravascular contrast of microbubbles without filtration into the intercellular area. Although Grazioli et al. 8 reported that central scars are only observed in lesions > 3 cm in size, there was an exception to this in the present study. FNH has a very slight oval hypoechoic appearance that can be observed using CEUS and no withdrawal of contrast was observed in the early portal venous phase, which is similar to the finding of Kim et al. 13 Dietrich et al., 12 however, did not report that the central scar in FNH was hypoechoic in the portal venous phase.
Overall, we believe that the dynamic phases of CEUS provide faithful images for achieving the differential diagnosis of FNH and HA, by illustrating the different perfusion and arterial morphological characteristics of both conditions. Contrast enhancement in the portal venous phase is, however, less helpful in differentiating FNH and HA due to uncertain factors relating to branches of the hepatic and portal veins.
In summary, the present small-scale study has indicated that CEUS may be a useful tool in revealing the microvascular metabolism of tumours and improving the diagnostic accuracy of HA. Further research using larger sample sizes is required.
